Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Oxybutinin Treatment for Boys With Posterior Urethral Valves
NCT04526353Phase 2Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Sep 2020
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxybutynin in Posterior urethral valves (PUV), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Sep 2020; status: recruiting.
02
Drugs
oxybutynin
03
Conditions
Posterior urethral valves (PUV)
Beyond the preview
Go deeper on NCT04526353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04526353.